威勝控股(03393.HK)2024年度純利增加35%至7.06億元 末期息0.38港元
格隆匯3月27日丨威勝控股(03393.HK)公佈年度業績,截至2024年12月31日止年度,營業額為人民幣87.17億元,增幅為20%。毛利增加18%至人民幣30.35億元,2024年整體毛利率為34.8%。年內公司擁有人應占純利增加35%至人民幣7.06億元。年內每股基本盈利為人民幣71.4分。董事會建議派發末期股息每股0.38港元。
年內,電AMI業務的收入為人民幣31.99億元,較2023年增加21%。通訊及流體AMI業務的收入為人民幣26.15億元,較2023年增加24%。ADO業務的收入為人民幣29.03億元,較2023年增加17%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.